![](Luminopia is the first FDA-cleared binocular therapy for amblyopia." name="description"/><meta content="Luminopia Binocular Therapy for Amblyopia" property="og:title"/><meta content="Luminopia is the first FDA-cleared binocular therapy for amblyopia." property="og:description"/><meta content="https://cdn.prod.website-files.com/65650d46320d701ba6ed16eb/66448015ac0153d4eed16d8d_Social%20Share%20Logo%201.91_1%20(1).png)
Luminopia
Luminopia Binocular Therapy for Amblyopia
Cambridge, United States · Founded 2016 · $21.7M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B2C
- Website
- luminopia.com
- Total Funding
- $21.7M
- Last Round
- $16.0M Series AJun 2023
- Rounds
- 3
About
Luminopia develops FDA-cleared VR-based binocular therapy for amblyopia (lazy eye) in children ages 4-12.
Summary
Luminopia is a Biotech company based in Cambridge, United States, founded in 2016. It has raised $21.7M in total across 3 rounds, most recently a $16.0M Series A round in Jun 2023. Investors include US Venture Partners and ShangBay Capital.
Tech & App Stack
7 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jun 2023
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...